Effect of valaciclovir on CD4 count decline in untreated HIV: an international randomized controlled trial

Tan, Darrell H S; Raboud, Janet M; Szadkowski, Leah; Grinsztejn, Beatriz; Madruga, José Valdez Ramalho; Figueroa, Maria Ines; Cahn, Pedro; Barton, Simon E; Clarke, Amanda; Fox, Julie; Zubyk, Wendy; Walmsley, Sharon L; VALIDATE Study Group.
Artículo en Inglés | ARCA | ID: arc-30406

Documentos relacionados

  1. Effect of valaciclovir on CD4 count decline in untreated HIV: an international randomized controlled trial.
  2. [Earlier case finding and immediate treatment of HIV: Time2Act].
  3. Effectiveness and safety of prenatal valacyclovir for congenital cytomegalovirus infection: systematic review and meta-analysis.
  4. Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients.
  5. Valaciclovir for Epstein-Barr Virus Suppression in Moderate-to-Severe COPD: A Randomized Double-Blind Placebo-Controlled Trial.
  6. New evidence on prognostic features, prevention and treatment of congenital Cytomegalovirus infection.
  7. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.
  8. Valaciclovir to prevent vertical transmission of cytomegalovirus after maternal primary infection during pregnancy: a randomised, double-blind, placebo-controlled trial.
  9. [Sexual transmission of HIV: effect of potent antiretroviral therapy].
  10. [Efficacy and safety of different doses of antiviral agents in the treatment of herpes zoster: a meta-analysis].